TNSN01115A1 - Composition en particules contenant de l'eletriptan, et procede pour sa production - Google Patents
Composition en particules contenant de l'eletriptan, et procede pour sa productionInfo
- Publication number
- TNSN01115A1 TNSN01115A1 TNTNSN01115A TNSN01115A TNSN01115A1 TN SN01115 A1 TNSN01115 A1 TN SN01115A1 TN TNSN01115 A TNTNSN01115 A TN TNSN01115A TN SN01115 A TNSN01115 A TN SN01115A TN SN01115 A1 TNSN01115 A1 TN SN01115A1
- Authority
- TN
- Tunisia
- Prior art keywords
- production
- composition containing
- particle composition
- containing eletriptan
- eletriptan
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Abstract
L'INVENTION CONCERNE UNE COMPOSITION PHARMACEUTIQUE SOUS FORME DE PARTICULES POUR L'ADMINISTRATION ORALE, COMPRENANT UN NOYAU CONTENANT DE L'ELETRIPTAN QUI EST REVETU D'UN ENROBAGE PERMEABLE INSOLUBLE DANS L'EAU. ELLE CONCERNE EGALEMENT UN PROCEDE POUR SA PREPARATION. APPLICATION : UTILISATION DE CETTE COMPOSITION DANS LE TRAITEMENT DE LA MIGRAINE ET LA PREVENTION DE LA RECURRENCE DE LA MIGRAINE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0018968.8A GB0018968D0 (en) | 2000-08-02 | 2000-08-02 | Particulate composition |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN01115A1 true TNSN01115A1 (fr) | 2005-11-10 |
Family
ID=9896843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN01115A TNSN01115A1 (fr) | 2000-08-02 | 2001-08-01 | Composition en particules contenant de l'eletriptan, et procede pour sa production |
Country Status (38)
Country | Link |
---|---|
US (1) | US20020034545A1 (fr) |
EP (1) | EP1365748B1 (fr) |
JP (1) | JP2004505034A (fr) |
KR (1) | KR20030024820A (fr) |
CN (1) | CN1630511A (fr) |
AP (1) | AP2001002233A0 (fr) |
AR (1) | AR030099A1 (fr) |
AT (1) | ATE308978T1 (fr) |
AU (1) | AU2001270932A1 (fr) |
BG (1) | BG107361A (fr) |
BR (1) | BR0112839A (fr) |
CA (1) | CA2417887C (fr) |
CZ (1) | CZ2003241A3 (fr) |
DE (1) | DE60114887T2 (fr) |
EA (1) | EA200300110A1 (fr) |
EC (1) | ECSP034451A (fr) |
EE (1) | EE200300051A (fr) |
ES (1) | ES2250429T3 (fr) |
GB (1) | GB0018968D0 (fr) |
GT (1) | GT200100149A (fr) |
HR (1) | HRP20030036A2 (fr) |
HU (1) | HUP0301453A2 (fr) |
IL (1) | IL153494A0 (fr) |
IS (1) | IS6649A (fr) |
MA (1) | MA26934A1 (fr) |
MX (1) | MXPA03000999A (fr) |
NO (1) | NO20030498D0 (fr) |
NZ (1) | NZ522976A (fr) |
OA (1) | OA12348A (fr) |
PA (1) | PA8523101A1 (fr) |
PE (1) | PE20020385A1 (fr) |
PL (1) | PL359847A1 (fr) |
SK (1) | SK1082003A3 (fr) |
SV (1) | SV2002000574A (fr) |
TN (1) | TNSN01115A1 (fr) |
UY (1) | UY26861A1 (fr) |
WO (1) | WO2002009675A1 (fr) |
ZA (1) | ZA200300868B (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040022853A1 (en) * | 2001-04-26 | 2004-02-05 | Control Delivery Systems, Inc. | Polymer-based, sustained release drug delivery system |
US20060134012A1 (en) * | 2002-12-16 | 2006-06-22 | Symington John M | Temporary pharmacologically-inactive dental coating for the in situ protection of dental therapeutic agents from saliva and abrasion from chewing |
JP2006522790A (ja) * | 2003-04-11 | 2006-10-05 | ファイザー・インク | エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物 |
GB2407498B (en) * | 2003-10-30 | 2008-06-11 | Cipla Ltd | Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient |
WO2005120456A2 (fr) * | 2004-06-09 | 2005-12-22 | Pfizer Limited | Nouvelle formulation de l'eletriptan |
WO2006013431A1 (fr) * | 2004-07-29 | 2006-02-09 | Pfizer Limited | Formulation pharmaceutique stable à libération régulée d’eletriptan |
KR20070115918A (ko) * | 2005-01-31 | 2007-12-06 | 교린 세이야꾸 가부시키 가이샤 | 멀티플 유닛형 경구 서방성 제제 및 그 제조방법 |
ES2434416T3 (es) | 2005-08-10 | 2013-12-16 | Add Advanced Drug Delivery Technologies, Ltd. | Preparación oral con liberación controlada |
US20070134322A1 (en) * | 2005-12-14 | 2007-06-14 | Forest Laboratories, Inc. | Modified and pulsatile release pharmaceutical formulations of escitalopram |
EP2359830B1 (fr) | 2006-04-26 | 2012-09-19 | Supernus Pharmaceuticals, Inc. | Préparations à libération contrôlée d'oxcarbazépine disposant d'un profil à libération sigmoïdale |
WO2008115797A1 (fr) * | 2007-03-16 | 2008-09-25 | Pavo, Inc. | Compositions thérapeutiques et procédés associés |
US8137661B2 (en) | 2007-07-25 | 2012-03-20 | Biolex Therapeutics, Inc. | Controlled release interferon drug products and treatment of HCV infections using same |
WO2011057676A1 (fr) * | 2009-11-16 | 2011-05-19 | Evonik Röhm Gmbh | Procédé de conversion d'un copolymère de (méth)acrylate solide en une forme dispersée au moyen d'un agent dispersant |
FR3025425A1 (fr) * | 2014-09-09 | 2016-03-11 | Charleston Lab Inc | Compositions pharmaceutiques |
GB201716716D0 (en) * | 2017-10-12 | 2017-11-29 | Univ Of Hertfordshire Higher Education Corporation | Method for coating particles |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2624732B1 (fr) * | 1987-12-21 | 1991-02-15 | Synthelabo | Formulation pharmaceutique a liberation prolongee |
US5411745A (en) * | 1994-05-25 | 1995-05-02 | Euro-Celtique, S.A. | Powder-layered morphine sulfate formulations |
GB9417310D0 (en) * | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
GB9825988D0 (en) * | 1998-11-27 | 1999-01-20 | Pfizer Ltd | Indole derivatives |
GB9922963D0 (en) * | 1999-09-28 | 1999-12-01 | Pfizer Ltd | Polymorphic salt |
FR2795962B1 (fr) * | 1999-07-08 | 2003-05-09 | Prographarm Laboratoires | Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif |
US20020044962A1 (en) * | 2000-06-06 | 2002-04-18 | Cherukuri S. Rao | Encapsulation products for controlled or extended release |
-
2000
- 2000-08-02 GB GBGB0018968.8A patent/GB0018968D0/en not_active Ceased
-
2001
- 2001-07-18 OA OA1200300020A patent/OA12348A/en unknown
- 2001-07-18 PL PL35984701A patent/PL359847A1/xx not_active Application Discontinuation
- 2001-07-18 SK SK108-2003A patent/SK1082003A3/sk not_active Application Discontinuation
- 2001-07-18 CN CNA018134041A patent/CN1630511A/zh active Pending
- 2001-07-18 KR KR10-2003-7001402A patent/KR20030024820A/ko not_active Application Discontinuation
- 2001-07-18 JP JP2002515228A patent/JP2004505034A/ja active Pending
- 2001-07-18 EA EA200300110A patent/EA200300110A1/ru unknown
- 2001-07-18 AU AU2001270932A patent/AU2001270932A1/en not_active Abandoned
- 2001-07-18 AP APAP/P/2001/002233A patent/AP2001002233A0/en unknown
- 2001-07-18 CA CA002417887A patent/CA2417887C/fr not_active Expired - Fee Related
- 2001-07-18 EE EEP200300051A patent/EE200300051A/xx unknown
- 2001-07-18 WO PCT/IB2001/001279 patent/WO2002009675A1/fr active IP Right Grant
- 2001-07-18 HU HU0301453A patent/HUP0301453A2/hu unknown
- 2001-07-18 ES ES01949819T patent/ES2250429T3/es not_active Expired - Lifetime
- 2001-07-18 CZ CZ2003241A patent/CZ2003241A3/cs unknown
- 2001-07-18 NZ NZ522976A patent/NZ522976A/en unknown
- 2001-07-18 MX MXPA03000999A patent/MXPA03000999A/es active IP Right Grant
- 2001-07-18 DE DE60114887T patent/DE60114887T2/de not_active Expired - Lifetime
- 2001-07-18 AT AT01949819T patent/ATE308978T1/de not_active IP Right Cessation
- 2001-07-18 EP EP01949819A patent/EP1365748B1/fr not_active Expired - Lifetime
- 2001-07-18 IL IL15349401A patent/IL153494A0/xx unknown
- 2001-07-18 BR BR0112839-6A patent/BR0112839A/pt not_active Application Discontinuation
- 2001-07-25 US US09/912,774 patent/US20020034545A1/en not_active Abandoned
- 2001-07-25 PA PA20018523101A patent/PA8523101A1/es unknown
- 2001-07-25 GT GT200100149A patent/GT200100149A/es unknown
- 2001-07-30 SV SV2001000574A patent/SV2002000574A/es not_active Application Discontinuation
- 2001-07-30 UY UY26861A patent/UY26861A1/es not_active Application Discontinuation
- 2001-08-01 TN TNTNSN01115A patent/TNSN01115A1/fr unknown
- 2001-08-01 PE PE2001000770A patent/PE20020385A1/es not_active Application Discontinuation
- 2001-08-01 AR ARP010103668A patent/AR030099A1/es unknown
-
2002
- 2002-12-05 IS IS6649A patent/IS6649A/is unknown
- 2002-12-06 BG BG107361A patent/BG107361A/bg unknown
-
2003
- 2003-01-21 HR HR20030036A patent/HRP20030036A2/hr not_active Application Discontinuation
- 2003-01-23 MA MA27009A patent/MA26934A1/fr unknown
- 2003-01-24 EC EC2003004451A patent/ECSP034451A/es unknown
- 2003-01-31 ZA ZA200300868A patent/ZA200300868B/en unknown
- 2003-01-31 NO NO20030498A patent/NO20030498D0/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN01115A1 (fr) | Composition en particules contenant de l'eletriptan, et procede pour sa production | |
TNSN99073A1 (fr) | Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN97139A1 (fr) | Derives d'acides d'arylsulfonylaminohydroxamiques | |
TNSN99055A1 (fr) | Derives bicycliques d'acide hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN96104A1 (fr) | Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant | |
TNSN99171A1 (fr) | 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN98017A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN99053A1 (fr) | Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydro- pyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant | |
TNSN98019A1 (fr) | Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN98111A1 (fr) | Tartrate d'un dipeptide substitue, procede pour sa preparation et compositions pharmaceutiques le contenant. | |
TNSN98022A1 (fr) | DERIVES DE N-HYDROXY-β-SULFONYLPROPIONAMIDE, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT. | |
TNSN99110A1 (fr) | Inhibiteurs non peptidiques de l'adhesion cellulaire sous la dependance de vla-4, procede pour leur preparation et compositions pharmaceutiques les contenant | |
BE900563A (fr) | Composition pharmaceutique pour le traitement d'etats d'insuffisance renale aigue. | |
BE1002109A3 (fr) | Composition pharmaceutique a activite analgesique. | |
JP2003524592A5 (fr) | ||
BE904547A (fr) | Nouveaux medicaments a usage topique. | |
TNSN00231A1 (fr) | Forme cristalline de 4-carboxyamino-2-substitue-1,2,3,4- tetrahydroquinoleine, et compositions la contenant | |
FR2787789B1 (fr) | Benzopyranes et benzoxepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparations | |
HUP0104088A2 (hu) | Késleltetett felszabadulású ranolazinkészítmények alkalmazása | |
TNSN98155A1 (fr) | Associations de compositions pharmaceutiques d'atorvastatine et d'agents antihypertensifs, et procede pour leur preparation | |
MA26420A1 (fr) | Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation. | |
TNSN97087A1 (fr) | 4(3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN97198A1 (fr) | Derives de 6-phenylpyridyl-2- amine et compositions pharmaceutiques les contenant | |
EP1598069A3 (fr) | Combinaison pharmaceutique d'éthinylestradiol et de drospirénone comme contraceptif | |
TNSN00251A1 (fr) | Forme posologique de sertraline stratifiee commandee par hydrogel |